Marjie L Hard - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Marjie L Hard

Showing results (11-20 of 13) with videos related to

Pageof 2

Sort By:

You have reached the last page of results.This site can display upto 13 results.

Pharmacology Research & Perspectives|February 12, 2021

Mass balance and pharmacokinetics of an oral dose of <sup>14</sup> C-napabucasin in healthy adult male subjectsXiaoshu Dai, Michael D Karol, Matthew Hitron, et al.

International Journal of Clinical Pharmacology and Therapeutics|February 20, 2014

Pharmacokinetics, safety and tolerability of mipomersen in healthy Japanese volunteers and comparison with Western subjectsZhaoyang Li, Marjie L Hard, Grit Andersen, et al.

Kidney International|March 4, 2011

A phase 1, single-dose study of fresolimumab, an anti-TGF-β antibody, in treatment-resistant primary focal segmental glomerulosclerosisHoward Trachtman, Fernando C Fervenza, Debbie S Gipson, et al.

Pageof 2

Search research articles

Showing results (11-20 of 13) with videos related to

Sort By:

Pageof 2

You have reached the last page of results.This site can display upto 13 results.

Pharmacology Research & Perspectives|February 12, 2021

Mass balance and pharmacokinetics of an oral dose of <sup>14</sup> C-napabucasin in healthy adult male subjectsXiaoshu Dai, Michael D Karol, Matthew Hitron, et al.

International Journal of Clinical Pharmacology and Therapeutics|February 20, 2014

Pharmacokinetics, safety and tolerability of mipomersen in healthy Japanese volunteers and comparison with Western subjectsZhaoyang Li, Marjie L Hard, Grit Andersen, et al.

Kidney International|March 4, 2011

A phase 1, single-dose study of fresolimumab, an anti-TGF-β antibody, in treatment-resistant primary focal segmental glomerulosclerosisHoward Trachtman, Fernando C Fervenza, Debbie S Gipson, et al.

Pageof 2